Among the companies with shares expected to actively trade in
Friday's session are OmniVision Technologies Inc. (OVTI), Krispy
Kreme Doughnuts Inc. (KKD) and Guess Inc. (GES).
OmniVision's fiscal fourth-quarter earnings surged as the chip
maker's revenue jumped, though margins continued to contract.
Shares soared 20% to $18.61 premarket as results topped the
company's expectations and as it provided guidance for the current
quarter above Walls Street estimates.
Krispy Kreme's fiscal first-quarter earnings jumped 33% as the
doughnut chain's revenue and domestic same-store sales continued to
improve. Shares climbed 10% to $15.70 premarket as results topped
analyst expectations and as the company lifted its full-year
earnings guidance.
Guess' fiscal first-quarter earnings fell 63% as the clothing
company reported lower sales from its North American and European
businesses. However, shares rose 6.6% to $31.29 premarket as
per-share earnings beat the company's own expectations, and revenue
fell in line.
Graphic Packaging Holding Co. (GPK) said certain of its
stockholders are offering 15 million shares. The packaging company,
which had around 347.5 million shares outstanding as of April 19,
won't receive any proceeds from the offering. Shares were down 3.9%
to $7.65 premarket.
Lions Gate Entertainment Corp. (LGF) swung to a fiscal
fourth-quarter profit as the movie studio reported stronger
revenue, while its bottom line was boosted by a large income-tax
benefit. Shares rose 4.1% to $29.19 premarket as results sharply
topped consensus estimates.
Palo Alto Networks Inc. (PANW) swung to a fiscal third-quarter
loss as significantly higher operating expenses offset the Internet
security company's improved revenue, and the latest period was
further hurt by income-tax provisions. Shares slid 13% to $47.50
premarket as revenue fell short of analyst expectations.
Vanda Pharmaceuticals Inc. (VNDA) said it has submitted a new
drug application to the U.S. Food and Drug Administration for
tasimelteon, a circadian regulator. Shares rose 5.7% to $9.72
premarket.
Watchlist:
Celgene Corp. (CELG) said a European Medicines Agency committee
has recommended approval of its oral anti-cancer therapy
pomalidomide for patients with relapsed and refractory multiple
myeloma.
CIT Group Inc. (CIT) will repurchase up to $200 million of stock
following the Federal Reserve Bank of New York's move to lift
restrictions it placed on the business lender during the financial
crisis.
Copart Inc.'s (CPRT) fiscal third-quarter earnings fell 4% as
the car auctioneer's increased expenses masked improved
revenue.
Esterline Technologies Corp.'s (ESL) fiscal second-quarter
earnings fell 21%--missing market expectations--as the specialty
manufacturer posted lighter sales for avionics and controls, as
well as sensors and systems.
Genesco Inc.'s (GCO) fiscal first-quarter earnings slipped 11%
as the seller of hats and footwear reported weaker same-store sales
amid a slow start to the period.
Pall Corp.'s (PLL) fiscal third-quarter earnings slid 7.4% as
the manufacturer of filtration and purification products booked a
loss from discontinued operations and as revenue in the industrial
segment weakened.
Standard & Poor's Ratings Services raised its outlook on
SanDisk Corp. (SNDK) to positive from stable, pointing to the flash
memory-maker's good revenue growth prospects.
Splunk Inc.'s (SPLK) fiscal first-quarter loss narrowed as the
data-analysis firm reported fewer charges, and revenue
increased.
Write to Anna Prior at anna.prior@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires